x

Turning science into breakthroughs

Accelerating the preclinical development of new drugs for improved quality of life and cures for disease

On December 18, 2019, Duke University and Deerfield Management announced the launch of Four Points Innovation, a strategic partnership focused on supporting and accelerating the translation of research into new therapies to treat and cure society’s most formidable healthcare challenges.

Through this partnership, Deerfield will fund Four Points Innovation with up to $130 million and provide development expertise in support of Duke’s innovative drug research across a span of high-need therapeutic areas.

Deerfield is a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com.

Duke is a private research university in Durham, North Carolina with nearly 16,000 undergraduate, graduate, and professional students and a world-class faculty helping to expand the frontiers of knowledge. The Duke School of Medicine is one of the nation’s leading centers for medical education, clinical care and biomedical research.

Timeline for Proposal Submissions

Proposal Sourcing

Principal Investigators are invited to submit proposals.

Scientific Review

Your proposal will be reviewed by members of our scientific team.

Full Proposal

If your idea is selected for further evaluation, you will be invited to submit a full proposal.

Investment Evaluated

Your proposal will be carefully evaluated for funding by Deerfield’s investment team.

For more information on proposal submissions, please reach out to the Four Points Scientific Collaboration Director, Bryan Baines, at bryan.baines@duke.edu.

Have more specific questions?

Find answers to commonly asked questions or submit a specific request.